Skip to main content

Table 3 Expression levels in RCC of patients with/without development of metastatic disease

From: Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

  Metastatic disease Relapse-free disease p-value
  n = 15 n = 23  
miRNA-155 6.07* 15.58 0.095
  1.80-21.03** 7.29-27.58  
miRNA-141 0.072 0.102 0.682
  0.033-0.671 0.046-0.181  
miRNA-210 36.758 41.137 0.317
  12.147-62.417 28.581-82.332  
miRNA-200c 0.266 0.301 0.502
  0.108-0.487 0.185-0.517  
miRNA-106a 14.522 25.126 0.081
  12.469-24.862 16.923-42.519  
miRNA-106b 10.387 16.451 0.030
  6.591-15.950 11.119-25.831  
miRNA-200b 6.556 7.804 0.87
  3.849-14.096 3.697-14.676  
miRNA-182 0.302 0.081 0.194
  0.051-0.728 0.036-0.321  
  1. * Medians of expression level related to RNU6B with **25th and 75th percentiles.